搜展位
搜全站
东莞康润实验科技有限公司
关注
已关注
银牌12年
已认证
粉丝量 0
400-860-5168转2796
仪器信息网认证电话，请放心拨打
产品介绍
| MM0018.06 | 盐酸环丙沙星单水合物 | 500mg | 12953 | Ciprofloxacin Hydrochloride Monohydrate | 含量测定 |
| MM0019.00 | 左美丙嗪马来酸 | 100mg | 12953 | Levomepromazine Maleate | 含量测定 |
| MM0019.01 | 左美丙嗪马来酸杂质B | 100mg | 12953 | Levomepromazine Maleate Imp. B (EP): 10-[(2R)-3-(Dimethylamino)-2-methylpropyl]-2-methoxy-10H-phenothiazine 5-Oxide (Levomepromazine S-Oxide) | 含量测定 |
| MM0019.02 | 左美丙嗪马来酸杂质A | 100mg | 12953 | Levomepromazine Maleate Imp. A (EP): 2-Methoxyphenothiazine | 含量测定 |
| MM0020.00 | 西米替丁 | 500mg | 12953 | Cimetidine | 含量测定 |
| MM0020.03 | 西米替丁杂质C | 100mg | 12953 | Cimetidine Hydrochloride Imp. C (EP) as Dihydrochloride: 1-[(Methylamino)[[2-[[(5-methyl-1H-imidazol-4-yl)-methyl]sulphanyl]ethyl]amino]methylene]urea Dihydrochloride (Cimetidine Amide Dihydrochloride) | 含量测定 |
| MM0020.04 | 西米替丁杂质E | 100mg | 12953 | Cimetidine Hydrochloride Imp. E (EP): 2-Cyano-1-methyl-3-[2-[[(5-methyl-1H-imidazol-4-yl)methyl]sulphinyl]ethyl]guanidine(Cimetidine Sulphoxide) | 含量测定 |
| MM0020.06 | 西米替丁杂质D | 100mg | 12953 | Cimetidine Hydrochloride Imp. D (EP) as Dihydrochloride:1-Methyl-3-[2-[[(5-methyl-1H-imidazol-4-yl)methyl]sulphanyl]ethyl]guanidineDihydrochloride | 含量测定 |
| MM0020.07 | 西米替丁杂质H | 100mg | 12953 | Cimetidine Hydrochloride Imp. H (Pharmeuropa): 1,1'-(Disulphanediyldiethylene)bis(2-cyano-3-methylguanidine) | 含量测定 |
| MM0020.08 | 西米替丁杂质A | 100mg | 12953 | Cimetidine Hydrochloride Imp. A (EP): 3-Cyano-2-methyl-1-[2-[[(5-methyl-1H-imidazol-4-yl)methyl]-sulphanyl]ethyl]isothiourea | 含量测定 |
| MM0020.12 | 西米替丁杂质B | 100mg | 12953 | Cimetidine Hydrochloride Imp. B (EP): 3-Cyano-2-methyl-1-[2-[[(5-methyl-1H-imidazol-4-yl)methyl]-sulphanyl]ethyl]isourea | 含量测定 |
| MM0020.15 | 西米替丁杂质G | 100mg | 12953 | Cimetidine Hydrochloride Imp. G (Pharmeuropa): 2-Cyano-1,3-dimethylguanidine | 含量测定 |
| MM0020.50 | 西米替丁杂质J | 100mg | 12953 | Cimetidine Hydrochloride Imp. J (Pharmeuropa) as Dihydrobromide: 2-[[(5-Methyl-1H-imidazol-4-yl)methyl]-sulphanyl]ethanamine Dihydrobromide | 含量测定 |
| MM0021.00 | 维生素B6 | 500mg | 12953 | Pyridoxine Hydrochloride | 含量测定 |
| MM0021.01 | 维生素B7杂质A | 100mg | 26235 | Pyridoxine Hydrochloride Imp. A (EP) as Hydrochloride: 6-Methyl-1,3-dihydrofuro[3,4-c]pyridin-7-olHydrochloride | 含量测定 |
| MM0021.02 | 维生素B8杂质B | 100mg | 12953 | Pyridoxine Hydrochloride Imp. B (EP) as Hydrochloride: 5-(Hydroxymethyl)-2,4-dimethylpyridin-3-ol Hydrochloride | 含量测定 |
| MM0021.03 | 吡哆辛乙酯 | 100mg | 12953 | Pyridoxine Diacetate | 含量测定 |
| MM0021.05 | 盐酸吡哆醛 | 100mg | 12953 | Pyridoxal Hydrochloride | 含量测定 |
| MM0021.06 | 盐酸吡多胺 | 100mg | 12953 | Pyridoxamine Dihydrochloride | 含量测定 |
| MM0021.07 | 4-吡哆酸 | 50mg | 26235 | 4-Pyridoxic Acid | 含量测定 |
| MM0022.00 | 维拉帕米盐酸盐 | 500mg | 12953 | Verapamil Hydrochloride | 含量测定 |
| MM0022.02 | 维拉帕米盐酸盐杂质D | 100mg | 12953 | Verapamil Hydrochloride Imp. D (EP): 3-Chloro-N-[2-(3,4-dimethoxyphenyl)ethyl]-N-methylpropan-1-amine | 含量测定 |
| MM0022.03 | 维拉帕米盐酸盐杂质K | 100mg | 12953 | Verapamil Hydrochloride Imp. K (EP): (2RS)-2-(3,4-Dimethoxyphenyl)-3-methylbutylnitrile | 含量测定 |
| MM0022.04 | 维拉帕米盐酸盐杂质G | 100mg | 4950 | Verapamil Hydrochloride Imp. G (EP): 3,4-Dimethoxybenzaldehyde | 含量测定 |
| MM0022.05 | 维拉帕米盐酸盐杂质E | 100mg | 4950 | Verapamil Hydrochloride Imp. E (EP): (3,4-Dimethoxyphenyl)methanol | 含量测定 |
| MM0022.07 | 维拉帕米盐酸盐杂质A | 100mg | 12953 | Verapamil Hydrochloride Imp. A (EP) as Dihydrochloride: N,N'-Bis[2-(3,4-dimethoxyphenyl)ethyl]-N,N'-dimethylpropane-1,3-diamine Dihydrochloride | 含量测定 |
| MM0022.08 | 维拉帕米盐酸盐杂质B | 100mg | 12953 | Verapamil Hydrochloride Imp. B (EP) as Hydrochloride: 2-(3,4-Dimethoxyphenyl)-N-methylethanamineHydrochloride | 含量测定 |
| MM0022.09 | 维拉帕米盐酸盐杂质C | 100mg | 12953 | Verapamil Hydrochloride Imp. C (EP) as Hydrochloride: 2-(3,4-Dimethoxyphenyl)-N,N-dimethylethan-amine Hydrochloride | 含量测定 |
| MM0022.10 | 维拉帕米盐酸盐杂质F | 100mg | 12953 | Verapamil Hydrochloride Imp. F (EP) as Hydrochloride: (2RS)-2-(3,4-Dimethoxyphenyl)-5-(methylamino)-2-(1-methylethyl)pentanenitrile Hydrochloride | 含量测定 |
| MM0022.11 | 维拉帕米盐酸盐杂质H | 100mg | 12953 | Verapamil Hydrochloride Imp. H (EP) as Hydrochloride: (2RS)-2-(3,4-Dimethoxyphenyl)-5-[[2-(3,4-dimethoxyphenyl)-ethyl](methyl)amino]-2-ethylpentanenitrile Hydrochloride | 含量测定 |
| MM0022.13 | 维拉帕米盐酸盐杂质L | 100mg | 12953 | Verapamil Hydrochloride Imp. L (EP): 1-(3,4-Dimethoxyphenyl)-2-methylpropan-1-one | 含量测定 |
| MM0022.16 | 维拉帕米盐酸盐杂质O | 100mg | 12953 | Verapamil Hydrochloride Imp. O (EP) as Hydrochloride: (2RS)-2-(3,4-Dimethoxyphenyl)-5-[2-[2-(3,4-dimethoxy-phenyl)ethyl](methyl)amino]- 2-propylpentane-nitrile Hydrochloride | 含量测定 |
| MM0022.19 | 维拉帕米氮氧化物盐酸盐 | 50mg | 6105 | Verapamil N-Oxide Hydrochloride | 含量测定 |
| MM0022.21 | 维拉帕米盐酸盐杂质J | 100mg | 12953 | Verapamil Hydrochloride Imp. J (EP) as Maleate: (2RS)- | 含量测定 |
| MM0023.00 | 地西泮 | 100mg | 12953 | Diazepam [Controlled Substance] | 含量测定 |
| MM0023.03 | 地西泮杂质C | 100mg | 12953 | Diazepam Imp. C (EP): 3-Amino-6-chloro-1-methyl-4-phenylquinolin-2(1H)-one | 含量测定 |
| MM0023.04 | 地西泮杂质B | 100mg | 12953 | Diazepam Imp. B (EP): 2-Chloro-N-(4-chloro-2-benzoylphenyl)-N-methylacetamide | 含量测定 |
| MM0024.00 | 乙酰半胱氨酸 | 500mg | 12953 | N-Acetyl-L-cysteine | 含量测定 |
| MM0024.01 | 乙酰半胱氨酸杂质D | 100mg | 12953 | Acetylcysteine Imp. D (EP): N,S-Diacetyl-L-cysteine | 含量测定 |
| MM0024.02 | 乙酰半胱氨酸杂质B | 100mg | 4950 | Acetylcysteine Imp. B (EP): L-Cysteine | 含量测定 |
| MM0024.03 | 乙酰半胱氨酸杂质A | 100mg | 4950 | Acetylcysteine Imp. A (EP): L-Cystine | 含量测定 |
| MM0024.04 | 乙酰半胱氨酸杂质C | 100mg | 12953 | Acetylcysteine Imp. C (EP): N,N'-Diacetyl-L-cystine | 含量测定 |
| MM0025.00 | 苯丁哌胺盐酸盐 | 500mg | 12953 | Loperamide Hydrochloride | 含量测定 |
| MM0025.04 | 苯丁哌胺盐酸盐杂质C | 100mg | 4950 | Loperamide Hydrochloride Imp. C (EP): 4-(4-Chlorophenyl)piperidin-4-ol | 含量测定 |
| MM0025.05 | 苯丁哌胺盐酸盐杂质D | 100mg | 12953 | Loperamide Hydrochloride Imp. D (EP): 4-(4-Hydroxy-4-phenylpiperidin-1-yl)-N,N-dimethyl-2,2-diphenylbutanamide | 含量测定 |
| MM0025.07 | 二苯基乙酸乙酯 | 100mg | 12953 | Ethyl Diphenylacetate | 含量测定 |
| MM0025.09 | 苯丁哌胺盐酸盐杂质F | 100mg | 12953 | Loperamide Hydrochloride Imp. F (EP): Loperamide Oxide | 含量测定 |
| MM0025.11 | 苯丁哌胺盐酸盐杂质H | 100mg | 12953 | Loperamide Hydrochloride Imp. H (EP): 4-[4-(4-Chlorophenyl)-3,6-dihydropyridin-1(2H)-yl]-N,N-dimethyl-2,2-diphenylbutanamide | 含量测定 |
| MM0025.15 | 苯丁哌胺盐酸盐杂质B | 100mg | 12953 | Loperamide Hydrochloride Imp. B (EP) as Bromide: 4-(4-Chlorophenyl)-1,1-bis[4-(dimethylamino)-4-oxo-3,3-diphenyl-butyl]-4-hydroxypiperidinium Bromide | 含量测定 |
| MM0026.00 | 青霉素V钾 | 250mg | 12953 | Phenoxymethylpenicillin Potassium | 含量测定 |
| MM0026.01 | 青霉素V钾杂质E | 100mg | 12953 | Phenoxymethylpenicillin Potassium Imp. E (EP): (4S)-2-[Carboxy[(phenoxyacetyl)amino]methyl]-5,5-dimethylthiazolidine-4-carboxylic Acid (Penicilloic Acids of Phenoxymethylpenicillin) | 含量测定 |
| MM0026.02 | 青霉素V钾杂质D | 100mg | 12953 | Phenoxymethylpenicillin Potassium Imp. D (EP): (2S,5R,6R)-3,3-Dimethyl-7-oxo-6-[[2-(4-hydroxyphenoxy)acetyl]amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylicAcid (4-Hydroxyphenoxymethylpenicillin) | 含量测定 |
| MM0026.03 | 青霉素V钾杂质B | 100mg | 4950 | Phenoxymethylpenicillin Potassium Imp. B (EP): Phenoxyacetic Acid | 含量测定 |
| MM0026.04 | 6-氨基青酶烷酸 | 100mg | 4950 | (2S,5R,6R)-6-Amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]-heptane-2-carboxylic Acid(6-Aminopenicillanic Acid) | 含量测定 |
| MM0026.05 | 青霉素V钾杂质F | 100mg | 12953 | Phenoxymethylpenicillin Potassium Imp. F (EP): (2RS,4S)-5,5-Dimethyl-2-[[(phenoxyacetyl)amino]methyl]thiazolidine-4-carboxylic Acid (Penilloic Acids of Phenoxymethylpenicillin) | 含量测定 |
| MM0027.00 | 酒石酸美托洛尔 | 500mg | 12953 | Metoprolol Tartrate | 含量测定 |
| MM0028.02 | 氯氮卓盐酸盐杂质A | 100mg | 12953 | Chlordiazepoxide Hydrochloride Imp. A (EP): 7-Chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one 4-Oxide(Demoxepam) | 含量测定 |
| MM0028.04 | 氯氮卓盐酸盐杂质B | 100mg | 12953 | Chlordiazepoxide Hydrochloride Imp. B (EP): 6-Chloro-2-(chloromethyl)-4-phenylquinazoline 3-Oxide | 含量测定 |
| MM0028.08 | 氯氮卓 | 100mg | 12953 | Chlordiazepoxide [Controlled Substance] | 含量测定 |
| MM0029.00 | 法莫替丁 | 250mg | 12953 | Famotidine | 含量测定 |
| MM0029.01 | 法莫替丁杂质C | 100mg | 12953 | Famotidine Imp. C (EP): 3-(2-Diaminomethylenamino-1,3-thiazol-4-ylmethyl-sulphanyl)-N-sulphamoylpropanamide | 含量测定 |
| MM0029.02 | 法莫替丁杂质D | 100mg | 12953 | Famotidine Imp. D (EP): 3-[[[2-[(Diaminomethylene)-amino]thiazol-4-yl]methyl]sulphanyl]propanamide | 含量测定 |
| MM0029.03 | 法莫替丁杂质F | 100mg | 12953 | Famotidine Imp. F (EP): 3-[[[2-[(Diaminomethylene)-amino]thiazol-4-yl]methyl]sulphanyl]propanoic Acid | 含量测定 |
盐酸环丙沙星单水合物信息由东莞康润实验科技有限公司为您提供，如您想了解更多关于盐酸环丙沙星单水合物报价、型号、参数等信息，欢迎来电或留言咨询。除供应盐酸环丙沙星单水合物外，东莞康润实验科技有限公司还可为您提供千金藤素 分析标准品 ≥98% C102706-10g CAS：481-49-2、HJ-1022-Mix HJ 1022 苯氧羧酸类农药混标（7项）、DPHP邻苯二甲酸二(2-丙基庚)酯 [CAS:53306-54-0]等产品，公司有专业的客户服务团队，是您值得信赖的合作伙伴。
工商信息
企业名称
东莞康润实验科技有限公司
企业信息已认证
企业类型
有限责任公司(自然人投资或控股)
信用代码
914419000599147479
成立日期
2012-12-18
注册资本
人民币壹佰万元
经营范围
批发:危险化学品(不设储存，不摆放样品，凭危险化学品经营许可证核定的项目经营);仪器仪表、电子产品、仪器设备、生物制品、玻璃制品的技术开发、技术咨询、技术服务及销售;销售:其他化工产品、电脑配件、劳保用品、五金交电、塑料制品、通讯设备、办公用品;货物及技术进出口。(依法须经批准的项目,经相关部门批准后方可开展经营活动。)
联系我们
广东博精科技有限公司
公司地址
东莞市厚街镇南环路新后街产业创新园G栋
客服电话
400-860-5168转2796
推荐产品
供应产品
联系我们：
企业名称： 广东博精科技有限公司
企业地址： 东莞市厚街镇南环路新后街产业创新园G栋 联系人： 石现永 邮编： 523965 联系电话： 400-860-5168转2796
主营产品：
友情链接：
仪器信息网APP
展位手机站